A novel neurotensin/xenin fusion peptide enhances β-cell function and exhibits antidiabetic efficacy in high-fat fed mice.

There was a tendency for glucose-induced insulin secretion to be augmented in all HFF treatment groups, but this failed to reach significance ( Figure 4 C,D).

also in 4,113 other papers